Table 1.
Baseline variable in the study and control groups
| Baseline Variables | Study Group (n=100) | Control Group (n=50) | P |
|---|---|---|---|
| Age (years) | 46.77±13.76 | 43.64±13.89 | 0.054 |
| Hb (g%) | 7.76±1.6 | 8.64±1.76 | 0.002 |
| TLC (per cu mm) | 6462.4±3486.72 | 7114.8±3797.35 | 0.255 |
| Platelet (per cu mm) | 88622±91194.23 | 97846±38379.94 | 0.0003 |
| Bilirubin (mg/dl) | 3.6±2.32 | 3.86±3.77 | 0.06 |
| SGOT (IU/L) | 84.33±70.4 | 93.82±71.42 | 0.063 |
| SGPT (IU/L) | 73.98±49.73 | 75.66±37.48 | 0.172 |
| ALP (IU/L) | 160.85±48.65 | 112.78±38.65 | <0.0001 |
| Creatinine (mg/dl) | 1.76±0.75 | 1.55±0.61 | 0.158 |
| Sodium (mg/dl) | 136.95±5.12 | 134.6±4.92 | 0.017 |
| Potassium (mEq/L) | 4.2±0.77 | 3.88±0.65 | 0.001 |
| PT | 16.47±2.94 | 15.72±2.41 | 0.108 |
| INR | 1.7±0.49 | 1.81±0.45 | 0.096 |
| 25-Hydroxyvitamin D Level (nmol/L) | 25.62±21.94 | 37.44±18.61 | <0.0001 |
Data expressed in Mean±SD unless specified, n: number, Hb: Hemoglobin, TLC: Total leucocyte count, SGOT: Serum glutamic-oxaloacetic transaminase, SGPT: Serum glutamic-pyruvic transaminase, ALP: Alkaline phosphatase, PT: Prothrombin time, INR: international normalized ratio